EA200601641A1 - Кристаллическая композиция, содержащая оксалат эсциталопрама - Google Patents

Кристаллическая композиция, содержащая оксалат эсциталопрама

Info

Publication number
EA200601641A1
EA200601641A1 EA200601641A EA200601641A EA200601641A1 EA 200601641 A1 EA200601641 A1 EA 200601641A1 EA 200601641 A EA200601641 A EA 200601641A EA 200601641 A EA200601641 A EA 200601641A EA 200601641 A1 EA200601641 A1 EA 200601641A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oxalate
particles
escytal
premax
composition containing
Prior art date
Application number
EA200601641A
Other languages
English (en)
Inventor
Ким Бейструп Енсен
Рикке Эва Хумбле
Кен Лильегрен
Троэльс Вольсгорд Кристенсен
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34921251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601641(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200601641A1 publication Critical patent/EA200601641A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В настоящем изобретении описаны кристаллические частицы оксалата эсциталопрама, имеющие широкое распределение размера частиц или содержащие 0,01% (мас./мас.) Z-4-(4-диметиламино-1-(4-фторфенил)бут-1-енил)-3-гидроксиметилбензонитрила, где указанные частицы пригодны для применения в непосредственном прессовании. Кроме того, в изобретении описана новая фармацевтическая единичная дозированная форма, содержащая такие кристаллические частицы оксалата эсциталопрама, а также способы получения таких кристаллических частиц оксалата эсциталопрама. Наконец, изобретение относится к способу уменьшения количества гидроксилсодержащих примесей в растворе циталопрама и эсциталопрама.
EA200601641A 2004-03-05 2005-02-21 Кристаллическая композиция, содержащая оксалат эсциталопрама EA200601641A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55090904P 2004-03-05 2004-03-05
DKPA200400382 2004-03-05
PCT/DK2005/000115 WO2005084643A1 (en) 2004-03-05 2005-02-21 Crystalline composition containing escitalopram oxalate

Publications (1)

Publication Number Publication Date
EA200601641A1 true EA200601641A1 (ru) 2006-12-29

Family

ID=34921251

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601641A EA200601641A1 (ru) 2004-03-05 2005-02-21 Кристаллическая композиция, содержащая оксалат эсциталопрама

Country Status (9)

Country Link
EP (1) EP1732514A1 (ru)
JP (1) JP2007526262A (ru)
AU (1) AU2005218713B2 (ru)
BR (1) BRPI0508266A (ru)
CA (1) CA2558198A1 (ru)
EA (1) EA200601641A1 (ru)
NO (1) NO20064499L (ru)
NZ (1) NZ549100A (ru)
WO (1) WO2005084643A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2086509A1 (en) * 2006-10-20 2009-08-12 Ratiopharm GmbH Escitalopram and solid pharmaceutical composition comprising the same
EP2116231A1 (en) * 2008-05-07 2009-11-11 Hexal Ag Granulate comprising escitalopram oxalate
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6554245B1 (ja) * 2019-01-31 2019-07-31 第一工業製薬株式会社 ２，２’−ビス（２−ヒドロキシエトキシ）−１，１’−ビナフタレン粉体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
KR20040030609A (ko) * 2001-05-01 2004-04-09 하. 룬트벡 아크티에 셀스카브 경상이성체성 순수 에스시탈로프람의 용도
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
ES2280892T3 (es) * 2001-07-31 2007-09-16 H. Lundbeck A/S Composicion cristalina que contiene escitalopram.
TWI306846B (en) * 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
RS51092B (sr) * 2002-12-23 2010-10-31 H. Lundbeck A/S. Escitalopram bromhidrat i postupak za njegovo pripremanje
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate

Also Published As

Publication number Publication date
JP2007526262A (ja) 2007-09-13
AU2005218713B2 (en) 2009-11-19
NO20064499L (no) 2006-12-04
AU2005218713A1 (en) 2005-09-15
EP1732514A1 (en) 2006-12-20
NZ549100A (en) 2010-02-26
BRPI0508266A (pt) 2007-07-31
CA2558198A1 (en) 2005-09-15
WO2005084643A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
MXPA05010682A (es) Compuestos novedosos.
BR0206164A (pt) Partìculas cristalinas de oxalato de escitalopram, método para a produção de partìculas cristalinas de oxalato de escitalopram, e, forma de dosagem unitária sólida
TW200510303A (en) Novel compounds
MXPA04003858A (es) Antagonistas de mch para el tratamiento de obesidad.
MXPA04004956A (es) Antagonistas de la hormona concentradora de melanina basados en la piperidina para tratamiento de la obesidad y de trastornos del sistema nervioso central.
MY142029A (en) Phenoxyacetic acid derivatives
EA200701123A1 (ru) Способ очистки транс-(-)-δ-тетрагидроканнабинола и транс-(+)-δ-тетрагидроканнобинола
HK1096673A1 (en) Compositions useful as inhibitors of protein kinases
RU2011117019A (ru) Композиции для ухода за полостью рта, содержащие сферические частицы аморфного кварца
SE0203713D0 (sv) Novel compounds
MXPA05007182A (es) Complejos de cristales de proteina y polimeros ionicos.
WO2004108133A3 (en) Modulators of vr1 receptor
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
MX2007005710A (es) Sales de hidroxibenzoato de compuestos de metanicotina.
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
EA200601641A1 (ru) Кристаллическая композиция, содержащая оксалат эсциталопрама
HK1079526A1 (en) A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
HK1121670A1 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
EA200601373A1 (ru) Нитрат бутоконазола высокой степени чистоты с частицами заданного размера и способ его получения
BRPI0408403A (pt) pó cristalino de triidrato de amoxicilina
NO20053673L (no) Nye antikonvulsanderivatsalter
WO2003106656A3 (en) SINGLE-DOMAIN COMPOUNDS ASSOCIATED WITH TDF AND THE LIKE THEREOF
EA201001740A1 (ru) Гранулят, содержащий эсциталопрама оксалат